Disclosure Table
The following companies are deemed to be in an offer period for the purposes of disclosure under the Rules of the Irish Takeover Panel:
Offeree: Horizon Therapeutics plc
Offer period commenced: 29 November 2022
$0.0001 ordinary shares; ISIN: IE00BQPVQZ61; NSI: 228,768,464
Offeror: Amgen Inc
Disclosure of dealings and positions in this offeror is not required
Offeror identified: 29 November 2022
Rule 2.6(a) deadline: 17.00 (New York Time) 10 January 2023
